Serological response to Nuvaxovid (NVX-CoV2373) vaccine given as a fifth dose in non- and low-responder kidney transplant recipients

Nephrol Dial Transplant. 2023 May 31;38(6):1564-1566. doi: 10.1093/ndt/gfad010.

Authors

Alexandra Nowak^{1

2}, Peter Hemmingsson^{1

2}, Marie Evans^{1

2}, Julia Wijkström^{1

2}

Affiliations

¹ Division of Renal Medicine, Department Clinical Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
² Department of Renal Medicine, Karolinska University Hospital, Stockholm, Sweden.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Viral
COVID-19 Vaccines
Humans
Kidney Transplantation* / adverse effects
Transplant Recipients
Vaccines*

Substances

NVX-CoV2373 adjuvated lipid nanoparticle
COVID-19 Vaccines
Vaccines
Antibodies, Viral